NVCT
Nuvectis Pharma, Inc.$19.15+0.86 (+4.70%)Prev Close$18.29·MCap$503.9M·P/E—·Vol108.6K·Yield—
▲
Buys (12M)
6
$2.29M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$2.29M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Nuvectis Pharma, Inc. (NVCT) has been exclusively buying, with 6 insider purchases totaling $2.29M and 0 insider sales totaling $0.00. The most recent insider transaction was by BENTSUR RON (director, 10 percent owner, officer: Chairman & CEO), who purchased $250.0K worth of shares on Jul 1, 2026. Nuvectis Pharma, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $503.9M.
NVCT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | BENTSUR RON | director, 10 percent owner, officer: Chairman & CEO | Buy | 12,500 | $20.00 | $250.0K | 3,688,424 |
| Jul 1, 2026 | Mosseri Marlio Charles | 10 percent owner | Buy | 50,000 | $18.32 | $916.0K | 3,186,576 |
| Nov 5, 2025 | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $5.72 | $28.6K | 0 |
| Nov 5, 2025 | Kaplan Matthew L. | Director | Buy | 11,000 | $5.84 | $64.2K | 0 |
| Nov 5, 2025 | Sanchez Juan | Director | Buy | 13,000 | $5.79 | $75.3K | 0 |
| Oct 23, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 154,770 | $6.18 | $957.1K0.6% OS | 0 |
| Jun 20, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 5,603 | $7.99 | $44.8K | 0 |
| Jun 17, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 33,442 | $8.06 | $269.5K | 0 |
| May 12, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 21,167 | $8.11 | $171.7K | 0 |
| May 6, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 27,311 | $8.60 | $234.8K | 0 |
| Feb 11, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 240,000 | $5.00 | $1.20M0.9% OS | 2,884,121 |
| Dec 26, 2024 | BENTSUR RON | Chairman & CEO | Buy | 4,500 | $4.65 | $20.9K | 3,270,924 |
| Dec 16, 2024 | Mosseri Marlio Charles | 10% Owner | Buy | 17,000 | $4.70 | $79.9K | 2,612,000 |
| Nov 20, 2024 | Poradosu Enrique | Chief Science & Business Off | Buy | 2,000 | $4.99 | $10.0K | 1,506,319 |
| Nov 18, 2024 | BENTSUR RON | Chairman & CEO | Buy | 20,000 | $4.92 | $98.4K | 3,266,424 |
| Nov 8, 2024 | Carson Michael J. | Vice President, Finance | Sell | 2,755 | $8.16 | $22.5K | 87,918 |
| May 15, 2024 | BENTSUR RON | Chairman & CEO | Buy | 1,940 | $6.74 | $13.1K | 3,246,424 |
| May 13, 2024 | BENTSUR RON | Chairman & CEO | Buy | 2,000 | $6.40 | $12.8K | 3,244,484 |
| May 13, 2024 | Poradosu Enrique | Chief Science & Business Off | Buy | 500 | $6.29 | $3.1K | 1,504,319 |
| May 13, 2024 | Shemesh Shay | Chief Dev. & Ops. Officer | Buy | 1,113 | $6.32 | $7.0K | 1,493,068 |
| Mar 19, 2024 | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $10.29 | $51.5K | 3,242,484 |
| Oct 12, 2023 | BENTSUR RON | Chairman & CEO | Buy | 640 | $11.08 | $7.1K | 3,237,484 |
| Oct 10, 2023 | BENTSUR RON | Chairman & CEO | Buy | 1,080 | $11.21 | $12.1K | 3,236,844 |
| Oct 6, 2023 | BENTSUR RON | Chairman & CEO | Buy | 3,220 | $11.01 | $35.5K | 3,235,764 |
| Aug 16, 2023 | BENTSUR RON | Chairman & CEO | Buy | 350 | $14.61 | $5.1K | 3,232,544 |
| Aug 11, 2023 | BENTSUR RON | Chairman & CEO | Buy | 300 | $14.73 | $4.4K | 3,232,194 |
| Aug 1, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 860 | $13.88 | $11.9K | 2,595,000 |
| Jul 31, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 2,584 | $13.91 | $35.9K | 2,594,140 |
| Jul 28, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 1,556 | $13.98 | $21.8K | 2,591,556 |
| Jul 27, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $13.97 | $139.7K | 2,590,000 |
| Jul 24, 2023 | BENTSUR RON | Chairman & CEO | Buy | 335 | $14.92 | $5.0K | 3,231,894 |
| Jul 24, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 8,238 | $14.47 | $119.2K | 2,580,000 |
| Jul 20, 2023 | BENTSUR RON | Chairman & CEO | Buy | 200 | $14.33 | $2.9K | 3,231,559 |
| Jul 20, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 8,000 | $14.84 | $118.7K | 2,571,762 |
| Jul 19, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 9,149 | $14.84 | $135.8K | 2,563,762 |
| Jul 18, 2023 | BENTSUR RON | Chairman & CEO | Buy | 260 | $15.52 | $4.0K | 3,231,359 |
| Jul 13, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 3,285 | $15.09 | $49.6K | 2,554,613 |
| Jul 12, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $15.36 | $153.6K | 2,551,328 |
| Jul 10, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 8,948 | $15.19 | $135.9K | 2,541,328 |
| Jul 7, 2023 | BENTSUR RON | Chairman & CEO | Buy | 320 | $14.88 | $4.8K | 3,231,099 |
| Jul 7, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 3,179 | $15.01 | $47.7K | 2,532,380 |
| Jul 6, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 1,176 | $15.52 | $18.3K | 2,529,201 |
| Jun 27, 2023 | BENTSUR RON | Chairman & CEO | Buy | 750 | $16.50 | $12.4K | 3,230,779 |
| Jun 27, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 16,760 | $16.46 | $275.9K | 2,528,025 |
| Jun 26, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 73,175 | $17.43 | $1.28M | 2,511,265 |
| Jun 23, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 13,090 | $17.72 | $232.0K | 2,438,090 |
| Jun 22, 2023 | BENTSUR RON | Chairman & CEO | Buy | 500 | $17.88 | $8.9K | 3,230,029 |
| Jun 20, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 12,700 | $17.75 | $225.4K | 2,425,000 |
| Jun 16, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 32,124 | $17.71 | $568.8K | 2,412,300 |
| Jun 8, 2023 | BENTSUR RON | Chairman & CEO | Buy | 350 | $17.45 | $6.1K | 3,229,529 |
Showing 1–50 of 94
1 / 2
NVCT Insider Buying Activity
The following table shows recent insider purchases of Nuvectis Pharma, Inc. (NVCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | BENTSUR RON | director, 10 percent owner, officer: Chairman & CEO | Buy | 12,500 | $20.00 | $250.0K | 3,688,424 |
| Jul 1, 2026 | Mosseri Marlio Charles | 10 percent owner | Buy | 50,000 | $18.32 | $916.0K | 3,186,576 |
| Nov 5, 2025 | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $5.72 | $28.6K | 0 |
| Nov 5, 2025 | Kaplan Matthew L. | Director | Buy | 11,000 | $5.84 | $64.2K | 0 |
| Nov 5, 2025 | Sanchez Juan | Director | Buy | 13,000 | $5.79 | $75.3K | 0 |
| Oct 23, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 154,770 | $6.18 | $957.1K0.6% OS | 0 |
| Jun 20, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 5,603 | $7.99 | $44.8K | 0 |
| Jun 17, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 33,442 | $8.06 | $269.5K | 0 |
| May 12, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 21,167 | $8.11 | $171.7K | 0 |
| May 6, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 27,311 | $8.60 | $234.8K | 0 |
| Feb 11, 2025 | Mosseri Marlio Charles | 10% Owner | Buy | 240,000 | $5.00 | $1.20M0.9% OS | 2,884,121 |
| Dec 26, 2024 | BENTSUR RON | Chairman & CEO | Buy | 4,500 | $4.65 | $20.9K | 3,270,924 |
| Dec 16, 2024 | Mosseri Marlio Charles | 10% Owner | Buy | 17,000 | $4.70 | $79.9K | 2,612,000 |
| Nov 20, 2024 | Poradosu Enrique | Chief Science & Business Off | Buy | 2,000 | $4.99 | $10.0K | 1,506,319 |
| Nov 18, 2024 | BENTSUR RON | Chairman & CEO | Buy | 20,000 | $4.92 | $98.4K | 3,266,424 |
| May 15, 2024 | BENTSUR RON | Chairman & CEO | Buy | 1,940 | $6.74 | $13.1K | 3,246,424 |
| May 13, 2024 | BENTSUR RON | Chairman & CEO | Buy | 2,000 | $6.40 | $12.8K | 3,244,484 |
| May 13, 2024 | Poradosu Enrique | Chief Science & Business Off | Buy | 500 | $6.29 | $3.1K | 1,504,319 |
| May 13, 2024 | Shemesh Shay | Chief Dev. & Ops. Officer | Buy | 1,113 | $6.32 | $7.0K | 1,493,068 |
| Mar 19, 2024 | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $10.29 | $51.5K | 3,242,484 |
| Oct 12, 2023 | BENTSUR RON | Chairman & CEO | Buy | 640 | $11.08 | $7.1K | 3,237,484 |
| Oct 10, 2023 | BENTSUR RON | Chairman & CEO | Buy | 1,080 | $11.21 | $12.1K | 3,236,844 |
| Oct 6, 2023 | BENTSUR RON | Chairman & CEO | Buy | 3,220 | $11.01 | $35.5K | 3,235,764 |
| Aug 16, 2023 | BENTSUR RON | Chairman & CEO | Buy | 350 | $14.61 | $5.1K | 3,232,544 |
| Aug 11, 2023 | BENTSUR RON | Chairman & CEO | Buy | 300 | $14.73 | $4.4K | 3,232,194 |
| Aug 1, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 860 | $13.88 | $11.9K | 2,595,000 |
| Jul 31, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 2,584 | $13.91 | $35.9K | 2,594,140 |
| Jul 28, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 1,556 | $13.98 | $21.8K | 2,591,556 |
| Jul 27, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $13.97 | $139.7K | 2,590,000 |
| Jul 24, 2023 | BENTSUR RON | Chairman & CEO | Buy | 335 | $14.92 | $5.0K | 3,231,894 |
| Jul 24, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 8,238 | $14.47 | $119.2K | 2,580,000 |
| Jul 20, 2023 | BENTSUR RON | Chairman & CEO | Buy | 200 | $14.33 | $2.9K | 3,231,559 |
| Jul 20, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 8,000 | $14.84 | $118.7K | 2,571,762 |
| Jul 19, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 9,149 | $14.84 | $135.8K | 2,563,762 |
| Jul 18, 2023 | BENTSUR RON | Chairman & CEO | Buy | 260 | $15.52 | $4.0K | 3,231,359 |
| Jul 13, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 3,285 | $15.09 | $49.6K | 2,554,613 |
| Jul 12, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $15.36 | $153.6K | 2,551,328 |
| Jul 10, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 8,948 | $15.19 | $135.9K | 2,541,328 |
| Jul 7, 2023 | BENTSUR RON | Chairman & CEO | Buy | 320 | $14.88 | $4.8K | 3,231,099 |
| Jul 7, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 3,179 | $15.01 | $47.7K | 2,532,380 |
| Jul 6, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 1,176 | $15.52 | $18.3K | 2,529,201 |
| Jun 27, 2023 | BENTSUR RON | Chairman & CEO | Buy | 750 | $16.50 | $12.4K | 3,230,779 |
| Jun 27, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 16,760 | $16.46 | $275.9K | 2,528,025 |
| Jun 26, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 73,175 | $17.43 | $1.28M | 2,511,265 |
| Jun 23, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 13,090 | $17.72 | $232.0K | 2,438,090 |
| Jun 22, 2023 | BENTSUR RON | Chairman & CEO | Buy | 500 | $17.88 | $8.9K | 3,230,029 |
| Jun 20, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 12,700 | $17.75 | $225.4K | 2,425,000 |
| Jun 16, 2023 | Mosseri Marlio Charles | 10% Owner | Buy | 32,124 | $17.71 | $568.8K | 2,412,300 |
| Jun 8, 2023 | BENTSUR RON | Chairman & CEO | Buy | 350 | $17.45 | $6.1K | 3,229,529 |
NVCT Insider Selling Activity
The following table shows recent insider sales of Nuvectis Pharma, Inc. (NVCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | Carson Michael J. | Vice President, Finance | Sell | 2,755 | $8.16 | $22.5K | 87,918 |
NVCT Insiders
BENTSUR RON
director, 10 percent owner, officer: Chairman & CEO
Bought $2.73M
47 tradesLast: Jul 1, 2026
Similar Stocks to NVCT
VRTX
Vertex Pharmaceuticals Incorporated
$477.65+0.30%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$663.61+1.12%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$279.45-0.67%
$43.19B
RVMD
Revolution Medicines, Inc.
$184.84-0.05%
$40.34B
MRNA
Moderna, Inc.
$67.74+0.44%
$27.09B
INSM
Insmed Incorporated
$109.74-0.32%
$25.06B
INCY
Incyte Corporation
$115.29+0.36%
$23.32B
UTHR
United Therapeutics Corporation
$532.36+1.05%
$23.22B